Clinical significance of IL-18 gene over-expression in AML.

[1]  G Flandrin,et al.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.

[2]  Establishment and characterization of human leukemia cell lines (J6-1, J6-2 and J6-3). , 1986 .

[3]  H. Drexler,et al.  Classification of acute myeloid leukemias--a comparison of FAB and immunophenotyping. , 1987, Leukemia.

[4]  F. Cozzolino,et al.  Interleukin 1 as an autocrine growth factor for acute myeloid leukemia cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Haman,et al.  Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor , 1989, The Journal of experimental medicine.

[6]  S. Piantadosi,et al.  Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem‐cell glycoprotein CD34 (My 10) , 1990, British journal of haematology.

[7]  S. Becker,et al.  Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. , 1991, Journal of immunology.

[8]  W. van Putten,et al.  Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. , 1993, The New England journal of medicine.

[9]  G. Zheng,et al.  Enhancement of J6-1 human leukemic cell proliferation by cell-cell contact: role of an M-CSF-like membrane-associated growth factor MAF-J6-1. , 1994, Leukemia research.

[10]  H. Okamura,et al.  Cloning of a new cytokine that induces IFN-γ production by T cells , 1995, Nature.

[11]  G. Marit,et al.  Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group. , 1995, Leukemia.

[12]  H. Okamura,et al.  IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. , 1996, Journal of immunology.

[13]  M. Slovak,et al.  Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. , 1997, Blood.

[14]  H. Kolb,et al.  Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. , 1997, The Journal of clinical investigation.

[15]  M. Ikeda,et al.  Characterization of anti-human interleukin-18 (IL-18)/interferon-gamma-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA. , 1997, Journal of immunological methods.

[16]  T. Tanimoto,et al.  Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. , 1997, Cancer research.

[17]  M. Su,et al.  Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting Enzyme , 1997, Science.

[18]  H. Okamura,et al.  IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. , 1997, Journal of immunology.

[19]  G. Zheng,et al.  Enhancement of J6-1 human leukemic cell proliferation by membrane-bound M-CSF through a cell-cell contact mechanism II. Role of an M-CSF receptor-like membrane protein. , 1998, Leukemia research.

[20]  C. Bloomfield,et al.  Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry , 1998, Leukemia.

[21]  H. Okamura,et al.  Regulation of interferon-γ production by IL-12 and IL-18 , 1998 .

[22]  J. Heesemann,et al.  IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. , 1998, Journal of immunology.

[23]  H. Okamura,et al.  Interleukin-18: a novel cytokine that augments both innate and acquired immunity. , 1998, Advances in immunology.

[24]  N. Horwood,et al.  Interleukin-18: perspectives on the newest interleukin. , 1998, Cytokine & growth factor reviews.

[25]  H. Okamura,et al.  IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. , 1998, Journal of immunology.

[26]  M. Lotz,et al.  IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. , 1999, Journal of immunology.

[27]  G. Zheng,et al.  Expression of membrane-associated macrophage colony-stimulating factor (M-CSF) in Hodgkin's disease and other hematologic malignancies. , 1999, Leukemia & lymphoma.

[28]  S. Clare,et al.  Interleukin 18 Contributes to Host Resistance and Gamma Interferon Production in Mice Infected with VirulentSalmonella typhimurium , 1999, Infection and Immunity.

[29]  K. Kohno,et al.  Oversecretion of IL‐18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity , 1999, British journal of haematology.

[30]  H. Okamura,et al.  Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells. , 1999, Anticancer research.

[31]  H. Okamura,et al.  Elevated interleukin (IL)‐18 levels during acute graft‐versus‐host disease after allogeneic bone marrow transplantation , 2000, British journal of haematology.

[32]  T. Nakao,et al.  Comparative Study on Complete Remission Rate and Overall Survival in Three Groups Classified Based on the Serum Interleukin-18 Level in Non-Hodgkin’s Lymphoma Patients , 2001, Acta Haematologica.

[33]  G. Zheng,et al.  Detection and sequencing analysis of IL-18 expression in J(6-1_ leukemic cells. , 2001, Leukemia research.

[34]  G. Zheng,et al.  Autocrine and possible intracrine regulation of HL-60 cell proliferation by macrophage colony-stimulating factor. , 2001, Leukemia research.

[35]  D. Hoelzer,et al.  AC133 expression on acute myeloid leukemia blasts: correlation to FAB and to CD34 expression and possible implications for peripheral blood progenitor cell purging in AML. , 2001, Leukemia research.

[36]  Expression of human interleukin-18 antigen in leukemia cells in a patient with acute mixed lineage leukemia. , 2001, Haematologia.